中国首个细胞药物有望在张江诞生 - 2021年06月07日

China's first cell therapy is expected to go to market from Shanghai's major innovative engine of Zhangjiang in the Pudong New Area, according to an expert at the 2nd Zhangjiang International Summit on Cell Therapy Industry held on Friday.
Today, nearly three out of four companies with application for cell therapy are based in Zhangjiang. What's more, in Zhangjiang, 15 projects have obtained the green light for clinical trials by April, accounting for more than one-fourth of the country's total.
Of them, Shanghai Hrain Biotechnology's dual-target CAR-T therapy is China's first of its kind to be approved to start clinical trials.